Treatment of diarrhea in patients with inflammatory bowel disease: Concepts and cautions

Reviews in Gastroenterological Disorders

Volumn 7, Issue SUPPL. 3, 2007, Pages

  Shah, Shamita B ^a   Hanauer, Stephen B ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Diarrhea; Inflammatory bowel disease; Loperamide; Malabsorption; Motility; Pathophysiologic mechanisms

Indexed keywords

ALOSETRON; AMINOSALICYLIC ACID; ANTIBIOTIC AGENT; ATROPINE; ATROPINE PLUS DIPHENOXYLATE; CIPROFLOXACIN; CODEINE SULFATE; COLESTYRAMINE; CORTICOSTEROID; COTRIMOXAZOLE; DICYCLOVERINE; DIPHENOXYLATE; HYDROCORTISONE; HYOSCYAMINE; IMMUNOMODULATING AGENT; ISPAGULA; LOPERAMIDE; MESALAZINE; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; OLSALAZINE; OPIATE; PLACEBO; PROTON PUMP INHIBITOR; RIFAXIMIN; TETRACYCLINE DERIVATIVE; TINCTURE OF OPIUM; UNCLASSIFIED DRUG; UNINDEXED DRUG; URSODEOXYCHOLIC ACID; VANCOMYCIN;

ALGORITHM; BACTERIAL INFECTION; BACTERIAL OVERGROWTH; CLINICAL TRIAL; COLITIS; COLON ABSORPTION; COLON MOTILITY; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG DOSE TITRATION; DRUG USE; ENTERITIS; EVALUATION; HUMAN; IATROGENIC DISEASE; INFLAMMATION; INTESTINE MOTILITY; MALABSORPTION; PATHOPHYSIOLOGY; REVIEW; SMALL BOWEL BACTERIAL OVERGROWTH; STEATORRHEA; SYMPTOM;

ANIMALS; ANTIDIARRHEALS; COLITIS, ULCERATIVE; CROHN DISEASE; DIARRHEA; GASTROINTESTINAL TRANSIT; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL ABSORPTION; LOPERAMIDE;

EID: 37849054354     PISSN: 1533001X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Wilson KT, Musch MW Chang EB. Diarrhea in inflammatory bowel disease. In: MacDermott R, Stenon W, eds. Inflammatory Bowel Disease. New York, NY: Elsevier Science; 1991:273-299.
2. Cronin CC, Shanahan F. Understanding the symptoms and signs in inflammatory bowel disease. In: Targan SR, Shanahan F, Karp LC, et al. Inflammatory Bowel Disease: From Bench to Bedside, 2nd ed. New York, NY: Springer Science and Media; 2005:253-267.
3. Urayama S, Chang EB. Mechanisms and treatment of diarrhea in inflammatory bowel diseases. Inflamm Bowel Dis. 1997;3:114-131.
4. Hanauer SB. Medical therapy for ulcerative colitis; Sandbom WJ. Medical therapy for Crohn's disease. In: Sartor RB, Sandborn W, eds. Kirsner's Inflammatory Bowel Diseases, 6th ed. Elsevier Inc; 2004:503-555.
5. Hofman AF, Poley JR. Role of bile acid malabsorption in pathogenesis of diarrhea and steatorrhea in patients with ileal resection. I. Response to cholestyramine or replacement of dietary long chain triglyceride by medium chain triglyceride. Gastroenterology. 1972;62:918-934.
6. Miner PB Jr. Factors influencing the relapse of patients with inflammatory bowel disease. Am J Gastroenterol. 1997;92:1S-4S.
7. Bayless TM, Harris ML. Inflammatory bowel disease and irritable bowel syndrome. Med Clin North Am. 1990;74:21-28.
8. Shen B, Achkar JP, Lashner BA, et al. Irritable pouch syndrome: a new category of diagnosis for symptomatic patients with ileal pouch-anal anastomosis. Am J Gastroenterol. 2002;97:972-977.
9. Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347:417-429.
10. Rodemann JF, Dubberke ER, Reske KA, et al. Incidence of clostridium difficile infection in inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2007;5:339-344.
11. Issa M, Vijayapal A, Graham MB, et al. Impact of clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007;5: 345-351.
12. Schiller L. Diarrhea following small bowel resection. In: Bayless T, Hanauer SB, eds. Advanced Therapy of Inflammatory Bowel Disease. Hamilton, Ontario: B.C. Decker Inc; 2001:471-474.
13. Pelemans W, Vantrappen F. A double blind crossover comparison of loperamide with diphenoxylate in the symptomatic treatment of chronic diarrhea. Gastroenterology. 1976;70: 1030-1034.
14. Verhaegen H, DeCree J, Schuermans V. Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 7: Clinical investigation. Efficacy and safety of loperamide in patients with severe chronic diarrhea. Arzneimittelforschung. 1974;24: 1657-1660.
15. Mainguet P, Fiasse R. Double-blind placebo-controlled study of loperamide (Imodium) in chronic diarrhoea caused by ileocolic disease or resection. Gut. 1977;18:575-579.
16. Tytgat GN. Loperamide and ileostomy output [corrrespondence]. Br Med J. 1975;3:489.
17. Tytgat GN, Huibregtse K. Loperamide and ileostomy output: placebo-controlled double-blind crossover study. Br Med J. 1975;2:667.
18. Cohen LD, Levitt MD. A comparison of the effect of loperamide in oral or suppository form vs placebo in patients with ileo-anal pouches. Colorectal Dis. 2001;3:95-99.
19. Pardi DS, Sandborn WJ. Systematic review: the management of pouchitis. Aliment Pharmacol Ther. 2006;23:1087-1096.
20. Fonkalsrud EW. Endorectal ileoanal anastomosis with isoperistaltic ileal reservoir after colectomy and mucosal proctectomy. Ann Surg. 1984;199: 151-157.
21. Thompson-Fawcett MW, Mortensen NJ, Warren BF. "Cuffitis" and inflammatory changes in the columnar cuff, anal transitional zone, and ileal reservoir after staples pouch-anal anastomosis. Dis Colon Rectum. 1999;42:348-355.
22. Brandt LJ, Bjorkman D, Fennerty MB, et al. Systematic review on the management of irritable bowel syndrome in North America. Am J Gastroenterol. 2002;97(11 Suppl):S7-S26.
23. Schiller LR, Santa Ana CA, Morawski SG, Fordtran JS. Mechanism of the antidiarrheal effect of loperamide. Gastroenterology. 1984;86:1475-1480.
24. Ruppin H. Review: loperamide - a potent antidiarrhoeal drug with actions along the alimentary tract. Aliment Pharmacol Ther. 1987;1:179-190.
25. Van Outryve M, Toussaint J. Loperamide oxide for the treatment of chronic diarrhoea in Crohn's disease. J Int Med Res. 1995;23:335-341.
26. Griffin MG, Miner PB. Review article: refractory distal colitis - explanation and options. Aliment Pharmacol Ther. 1996;10:39-48.
27. Hanauer SB. Drug therapy. N Engl J Med. 1996; 334:841-849.
28. Ericsson CD, Johnson PC. Safety and efficacy of loperamide. Am J Med. 1990;88:10S-14S.
29. Dettmer A. Loperamide oxide in the treatment of acute diarrhea in adults. Clin Ther. 1994;16: 972-980.
30. Sun WM, Read NW, Verlinden M. Effects of loperamide oxide on gastrointestinal transit time and anorectal function in patients with chronic diarrhoea and faecal incontinence. Scand J Gastroenterol. 1997;32:34-38.
31. Herbst F, Kamm MA, Nicholls RJ. Effects of loperamide on ileoanal pouch function. Br J Surg. 1998;85:1428-1432.
32. Oldfield EC 3rd. Is loperamide contraindicated in the treatment of bacillary dysentery? Am J Gastroenterol. 1995;90:327-328.
33. Emblem R, Stien R, Morkrid L. The effect of loperamide on bowel habits and anal sphincter function in patients with ileoanal anastomosis. Scand J Gastroenterol. 1989;24:1019-1024.